Atterocor debuts with $16 million
13:46 EDT 3 Aug 2012 | BioCentury
Newco Atterocor Inc. (Ann Arbor, Mich.) debuted on Friday with $16 million in a series A round led by Frazier Healthcare and 5AM Ventures. Atterocor is developing therapies to treat adrenal cancer. The company said it will provide details on its targ..
Original Article: Atterocor debuts with $16 million
More From BioPortfolio on "Atterocor debuts with $16 million"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
